Dementia is a big deal. It's when your brain starts to slow down, and it's not just one thing. Alzheimer's disease (AD) and frontotemporal dementia (FTD) are two big types, and they act differently over time. The challenge is, they start off looking the same. So, spotting them early is super importa
Plantain, also known as Plantago lanceolata, is a common plant that has been used for centuries in traditional medicine. It's been recognized as safe by various pharmacopeias, which are like rulebooks for medicines. This study looked at how different parts of the plant, specifically the leaves, migh
Two big trials are underway to test a new drug called oral semaglutide. These trials, known as Evoke and Evoke+, are in their third phase and are looking at how safe and effective this drug is for people in the early stages of Alzheimer's disease. Why is this important? Well, Alzheimer's is a t
Alzheimer's disease is a tough opponent, but scientists are finding new ways to fight it. Gold nanoparticles, tiny particles made of gold, are proving to be a powerful tool in the battle against this neurodegenerative disease. These nanoparticles can be loaded with afzelin, a natural compound found
Imagine if there were drugs that could tackle brain diseases in a whole new way. Brain diseases like Parkinson's and Alzheimer's are tough. They cause brain cells to die. Most drugs out there just treat the symptoms. They don't fix the root cause. This is where hybrid drugs come in. These are specia
People often struggle to recognize Alzheimer's disease and related dementias. But, there are tiny hints in the blood that could help doctors. These are called blood-based biomarkers, or BBMs. They act as signals that something might be wrong in the brain. But what happens when someone has other heal
At first glance, tau and CPEB3 might seem like an unlikely duo. Tau is a protein that can go rogue and form harmful clumps in Alzheimer's disease. On the other hand, CPEB3 is essential for long-term memory and forms functional clumps to do its job. So, what happens when these two memory-related prot
Alzheimer's disease is a tough opponent in the world of neurodegenerative disorders. Early detection is crucial. Scientists have been trying to figure out the best ways to identify this disease early. They've decided to focus on two key biomarkers Aβ42 and Aβ40. These biomarkers are tiny clues th
Researchers have found a strong link between a specific protein in blood, called phosphorylated tau217, and memory problems in people with Alzheimer's disease. This protein, found in plasma, can hint at the earlier stages of Alzheimer's. While scientists already knew that these proteins could show c
Alzheimer's disease is a growing concern, expected to affect 152 million people by 2050. Recently, new therapies, known as anti-amyloid treatments, have been approved. Unlike traditional options, these are infused every 2 to 5 weeks to slow down the disease. But with this progress comes a downside.
